Laura L. Worth

3.5k total citations
64 papers, 2.1k citations indexed

About

Laura L. Worth is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Laura L. Worth has authored 64 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 19 papers in Molecular Biology and 17 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Laura L. Worth's work include Hematopoietic Stem Cell Transplantation (21 papers), Acute Lymphoblastic Leukemia research (17 papers) and Acute Myeloid Leukemia Research (11 papers). Laura L. Worth is often cited by papers focused on Hematopoietic Stem Cell Transplantation (21 papers), Acute Lymphoblastic Leukemia research (17 papers) and Acute Myeloid Leukemia Research (11 papers). Laura L. Worth collaborates with scholars based in United States and Egypt. Laura L. Worth's co-authors include Eugenie S. Kleinerman, Shu-Fang Jia, Nadezhda V. Koshkina, Richard E. Champlin, Elizabeth J. Shpall, Zhichao Zhou, Demetrios Petropoulos, John M. Opitz, Charles S. Cox and Seymour Kessler and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Laura L. Worth

61 papers receiving 2.0k citations

Peers

Countries citing papers authored by Laura L. Worth

Since Specialization

Citations

This map shows the geographic impact of Laura L. Worth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura L. Worth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura L. Worth more than expected).

Fields of papers citing papers by Laura L. Worth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura L. Worth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura L. Worth. The network helps show where Laura L. Worth may publish in the future.

Co-authorship network of co-authors of Laura L. Worth

This figure shows the co-authorship network connecting the top 25 collaborators of Laura L. Worth. A scholar is included among the top collaborators of Laura L. Worth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura L. Worth. Laura L. Worth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia 2012 ·Bone Marrow Transplantation ·Limei Poon, Roland L. Bassett, Gabriela Rondón, Amir Hamdi, Muzaffar H. Qazilbash, Chitra Hosing, R B Jones, Elizabeth J. Shpall, Uday Popat, Yago Nieto, Laura L. Worth, Laurence J.N. Cooper, Marcos de Lima, R. Champlin, Partow Kebriaei	33
2	Long-Term Follow-up of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Impact of Tyrosine Kinase Inhibitors on Treatment Outcomes 2011 ·Biology of Blood and Marrow Transplantation ·Partow Kebriaei, Rima M. Saliba, Gabriela Rondón, (unknown), Rajyalakshmi Luthra, Paolo Anderlini, Börje S. Andersson, Elizabeth J. Shpall, Uday Popat, Roy B. Jones, Laura L. Worth, Farhad Ravandi, Deborah A. Thomas, Susan O’Brien, Hagop M. Kantarjian, M. Lima, Sergio Giralt, Richard E. Champlin	50
3	Addressing the Unmet Social Needs Of the Aya Stem Cell Transplant Patient 2009 ·Biology of Blood and Marrow Transplantation ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), J. Neumann, (unknown), Laura L. Worth, (unknown)	0
4	Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT 2009 ·Bone Marrow Transplantation ·Stefan O. Ciurea, Rima M. Saliba, Gabriela Rondón, Susana Pesoa, Pedro Cano, Marcelo Fernández-Viña, S. Qureshi, Laura L. Worth, J. McMannis, Partow Kebriaei, Roy B. Jones, M Körbling, Muzaffar H. Qazilbash, Elizabeth J. Shpall, Sergio Giralt, Marcos de Lima, Richard E. Champlin, James Gajewski	42
5	Infections in 100 Cord Blood Transplantations 2007 ·Medicine ·Amar Safdar, Gilhen Rodriguez, Marcos J. de Lima, Demetrios Petropoulos, Roy F. Chemaly, Laura L. Worth, Elizabeth J. Shpall, Kenneth V. I. Rolston, Issam Raad, Ka Wah Chan, Richard E. Champlin	36
6	Interferon-α after autologous stem cell transplantation in pediatric patients with advanced Hodgkin's lymphoma 2006 ·Bone Marrow Transplantation ·Dimitrios Petropoulos, Laura L. Worth, Craig A. Mullen, (unknown), Mary Choroszy, K. W. Chan	5
7	Production of VEGF165 by Ewing's sarcoma cells induces vasculogenesis and the incorporation of CD34⁺ stem cells into the expanding tumor vasculature 2006 ·International Journal of Cancer ·(unknown), Marcela F. Bolontrade, Laura L. Worth, Hui Guan, Lee M. Ellis, Eugenie S. Kleinerman	37
8	Intratumor murine interleukin-12 gene therapy suppressed the growth of local and distant Ewing's sarcoma 2006 ·Cancer Gene Therapy ·(unknown), (unknown), Laura L. Worth, Hui Guan, Eugenie S. Kleinerman	13
9	The role of interferon gamma and NK cells in the eradication of pulmonary osteosarcoma metastases by IL-12 2005 ·Cancer Research ·Lisa Mills, Gangxiong Huang, Laura L. Worth	3
10	Pharmacokinetics and individualized dose adjustment of intravenous busulfan in children with advanced hematologic malignancies undergoing allogeneic stem cell transplantation 2004 ·Biology of Blood and Marrow Transplantation ·Hai T. Tran, Demetrios Petropoulos, Laura L. Worth, Craig A. Mullen, Timothy Madden, B Andersson, Mary Choroszy, John Nguyen, (unknown), Ka Wah Chan	50
11	Fludarabine and Once-Daily Intravenous Busulfan for Allogeneic Bone Marrow Transplantation for Chediak-Higashi Syndrome 2003 ·Journal of Pediatric Hematology/Oncology ·Nancy Gordon, Craig A. Mullen, Hai T. Tran, Laura L. Worth, (unknown), Ka Wah Chan	7
12	Treatment of leukemia relapse with recombinant granulocyte‐macrophage colony stimulating factor (rhGM‐CSF) following unrelated umbilical cord blood transplant: Induction of graft‐vs.‐leukemia 2002 ·Pediatric Transplantation ·Laura L. Worth, Craig A. Mullen, Mary Choroszy, (unknown), Ka‐Wah Chan	2
13	Growth suppression of established human osteosarcoma lung metastases in mice by aerosol gene therapy with PEI– p53 complexes 2001 ·Cancer Gene Therapy ·Charles L. Densmore, Eugenie S. Kleinerman, Ajay Kumar Gautam, Shu-Fang Jia, Bo Xu, Laura L. Worth, J. Clifford Waldrep, Y K Fung, Anne Tang, Vernon Knight	53
14	Human bone marrow transplant rejection is associated with telomere cleavage 2001 ·International Journal of Molecular Medicine ·Asha S. Multani, Laura L. Worth, Sima Jeha, Ka Wah Chan, Sen Pathak	1
15	9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice. 2000 ·PubMed ·Nadezhda V. Koshkina, Eugenie S. Kleinerman, (unknown), (unknown), Laura L. Worth, Brian E. Gilbert, Vernon Knight	85
16	Interferon-alpha Enhances the Sensitivity of Human Osteosarcoma Cells to Etoposide 1999 ·Journal of Interferon & Cytokine Research ·(unknown), (unknown), Laura L. Worth, Eugenie S. Kleinerman	12
17	ImmTher, a lipophilic disaccharide derivative of muramyl dipeptide, up-regulates specific monocyte cytokine genes and activates monocyte-mediated tumoricidal activity 1999 ·Cancer Immunology Immunotherapy ·Laura L. Worth, Shu-Fang Jia, (unknown), Eugenie S. Kleinerman	22
18	A nude mouse model of human osteosarcoma lung metastases for evaluating new therapeutic strategies 1999 ·Clinical & Experimental Metastasis ·Shu-Fang Jia, Laura L. Worth, Eugenie S. Kleinerman	121
19	Development of a subdural vein thrombosis following aggressive factor VII replacement for postnatal intracranial haemorrhage in a homozygous factor VII‐deficient infant 1998 ·Haemophilia ·Laura L. Worth, W. Keith Hoots	15
20	Multisite Phosphorylation of Ornithine Decarboxylase in Transformed Macrophages Results in Increased Intracellular Enzyme Stability and Catalytic Efficiency 1996 ·Journal of Biological Chemistry ·(unknown), (unknown), Barbara Cochran, Laura L. Worth, (unknown), Patricia J. Brown, Victoria P. Knutson, Mari K. Haddox	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact